China rises as a biotech powerhouse, developing drugs to treat the world

Biotech once looked to China for cheap labor. It may soon find mounting competition instead.

Thanks to bountiful investments and loosening regulations, China has become a nascent biotech powerhouse that investors and entrepreneurs say could one day rival the industry’s Western incumbents. Fueled by a sudden influx of foreign-trained talent, a new generation of Chinese startups is racing to treat the world with medicines invented at home.

China’s rapid rise came into relief earlier this month at the annual meeting of the American Society of Clinical Oncology, often called the Super Bowl for biotech stocks because companies race to put out data on experimental

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readPolitics
After A Long Fight, Progressives Secure Small Tweaks To Pelosi’s Drug Pricing Package
Progressives are finally on board with Pelosi’s sweeping drug pricing bill after securing two small concessions.
STAT7 min read
Surgeons Test-drive The Amputation Of The Future With A Mail-order Limb, Rerouted Nerve, And Prosthetic Hand That Grips Like The Real Thing
WALTHAM, Mass. — The surgeons, peering through loupes with 3x magnification, have dissected away the skin, the layers of fat and fascia, and exposed most of the median nerve, the I-95 of the forearm. Sensory signals travel up this cable from the fing
STAT3 min readPolitics
It’s A Bonanza: With Drug Pricing Bill Up For A Vote, D.C. News Outlets Are Drowning In Advocacy Ads
On Wednesday alone, five D.C. newspapers ran nearly 20 ads urging lawmakers to oppose the major drug pricing bill up for consideration this week.